Yves Vanrenterghem

Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation

Henrik Ekberg, Hélio Tedesco‐Silva, A. Demirbaş et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text

Medicine, Nephrology, Pharmacokinetics +14

PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION

Josep M. Grinyó, CG Groth, R. Pichlmayr et al. · Data Archiving and Networked Services (DANS) · 1995 · 979 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1

A. David Mayer, Jan Dmitrewski, Jean-Paul Squifflet et al. · Transplantation · 1997 · 733 citations

Medicine, Immunology, Kidney Transplantation +9

A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1

Teun van Gelder, Luuk B. Hilbrands, Yves Vanrenterghem et al. · Transplantation · 1999 · 540 citations

Medicine, Pharmacokinetics, Pharmacology +17

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*

Michael Hale, Andrew Nicholls, Roy Bullingham et al. · Clinical Pharmacology & Therapeutics · 1998 · 399 citations

Medicine, Pharmacokinetics, Pharmacology +16